Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in ZTS — Zoetis Inc.

CIK 1273087 NEW YORK, NY
Back to ZTS Full portfolio

Position in ZTS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$195,041,180
+$151,220,213 QoQ
Shares Held
1,649,955
+373.7% QoQ
Ownership
0.394%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Derivatives in ZTS

reported options exposure · as of Mar 31, 2026
CallValue
$13,523,224
CallShares
114,400
PutValue
$4,361,949
PutShares
36,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $1,131,904,343 across 44 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (17.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
This page 		1,649,955 $195,041,180
2 SUPN
Supernus Pharmaceuticals, Inc.
 3,315,973 $171,402,644
3 NBIX
Neurocrine Biosciences Inc
 1,247,447 $164,338,667
4 INDV
Indivior Pharmaceuticals, Inc.
 4,595,535 $140,071,906
5 UTHR
UNITED THERAPEUTICS Corp
 153,372 $90,946,528
6 TEVA
Teva Pharmaceutical Industries Ltd
 1,893,845 $57,042,611
7 PRGO
PERRIGO Co plc
 4,279,731 $45,964,310
8 ANIP
Ani Pharmaceuticals Inc
 592,013 $45,525,799

All Filings in ZTS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,523,224 114,400
2026-03-31 $4,361,949 36,900
2026-03-31 $195,041,180 1,649,955
2025-12-31 $43,820,967 348,283
2025-12-31 $6,693,624 53,200
2025-12-31 $2,239,596 17,800
2025-09-30 $3,584,840 24,500
2025-09-30 $1,741,208 11,900
2025-09-30 $48,227,364 329,602
2025-06-30 $183,210,839 1,174,805
2025-06-30 $2,885,075 18,500
2025-06-30 $37,583,950 241,000
2025-03-31 $20,202,555 122,700
2025-03-31 $11,591,360 70,400
2025-03-31 $89,640,070 544,428
2024-12-31 $69,313,191 425,417
2024-12-31 $11,470,272 70,400
2024-12-31 $67,420,434 413,800
2024-09-30 $4,337,436 22,200
2024-09-30 $22,009,947 112,652
2024-09-30 $13,696,138 70,100
2024-06-30 $16,226,496 93,600
2024-06-30 $68,984,451 397,926
2024-06-30 $21,253,936 122,600
2024-03-31 $146,097,606 863,410
2024-03-31 $162,627,731 961,100
2024-03-31 $25,872,209 152,900
2023-12-31 $20,590,822 104,326
2023-12-31 $8,901,387 45,100
2023-12-31 $21,612,015 109,500
2023-09-30 $9,429,716 54,200
2023-09-30 $19,868,516 114,200
2023-09-30 $33,241,314 191,064
2023-06-30 $413,304 2,400
2023-06-30 $1,653,216 9,600
2023-06-30 $49,318,533 286,386
2023-03-31 $2,413,380 14,500
2023-03-31 $3,328,800 20,000
2023-03-31 $71,574,359 430,031
2022-12-31 $1,861,185 12,700
2022-12-31 $140,308,582 957,411
2022-12-31 $1,231,020 8,400
2022-09-30 $90,105,600 607,631
2022-09-30 $593,160 4,000
2022-09-30 $5,190,150 35,000
2022-06-30 $1,340,742 7,800
2022-06-30 $92,505,009 538,164
2022-06-30 $6,153,662 35,800
2022-03-31 $140,673,429 745,922
2021-12-31 $13,995,852 57,353

Report a Problem

Category
Description
Email (optional, for follow-up)